Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

In de ambulante geestelijke gezondheidszorg vinden protocollaire behandelingen steeds meer hun weg naar de dagelijkse praktijk, ondanks kritiek en discussie. De kritiek is begrijpelijk, maar de aantrekkingskracht niet minder. Protocollaire behandelingen zijn nuttige en betrouwbare behandelingen gebleken die op indicatie, of in combinatie met geïndividualiseerde behandelingen kunnen worden toegepast. Tevens groeit het besef dat protocollaire behandelingen weliswaar strikt gevolgd móesten worden in het wetenschappelijk onderzoek waaruit ze voortkwamen, maar dat de behandelaar in de praktijk zich daar minder aan hoeft te houden. Het gedetailleerde protocol is gebruikersvriendelijk, compleet, gestructureerd, goed uitvoerbaar en houdt de behandeling gericht op de stoornis waarvoor deze bedoeld is. In Protocollaire behandelingen in de ambulante geestelijke gezondheidszorg I en II zijn in totaal eenentwintig ambulant uitvoerbare, stoornisspecifieke protocollaire behandelingen gebundeld. Beide bundels zijn volledig herzien en geactualiseerd. In deel I zijn de protocollaire behandelingen opgenomen voor patiënten met: paniekstoornis - obsessieve-compulsieve stoornis - gegeneraliseerde angststoornis - acute stressstoornis - depressie - onverklaarde lichamelijke klachten - migraine en spanningshoofdpijn - ongewenste gewoonten - ticstoornissen en het syndroom van Gilles de la Tourette en voor pedoseksuele delictplegers en paren met relatieproblemen. Het eerste hoofdstuk uit deze bundel biedt daarnaast een kritische bespreking van protocollaire psychologische behandelingen in de geestelijke gezondheidszorg. De ontwikkeling van de serie Behandelingsstrategieën en de organisatie van de eraan gekoppelde symposia zijn initiatieven van cure & care development. CCd wil hiermee een bijdrage leveren aan de ontwikkeling van standaarden en strategieën die leiden tot kwaliteits- en efficiencyverbetering in de gezondheidszorg.

Psychiatry --- procedures --- fantasy --- rollenspelen --- psychiatrische behandelingsmethoden --- burn-out --- depressies --- sociale vaardigheden --- fobieën --- PTSS (posttraumatische stress-stoornis) --- paniek --- boulimia nervosa --- therapiekeuze --- dwangstoornissen --- cognitieve therapie --- hypochondrie --- cue-exposure --- exposure --- agorafobie --- tijdmanagement

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Addiction in its various forms represents an enormous challenge to society. Worldwide, it has been estimated that alcohol, tobacco and illicit drugs were responsible of more than 10 million deaths (Anderson et al, 2018), with a higher impact in developed countries where substance use disorders have been identified as responsible for life expectancy reversals (Rehm et al, 2016). Societal and medical responses to the problem are far from optimal, but the appearance of new technologies offers room for improvement, and lots of new initiatives have been launched and developed. In this Special Issue, we will describe and discuss how these new tools are helping to improve the assessment and treatment of substance use disorders. We will cover a wide variety of novelties that are being applied to addiction; e-health, APPs, digital phenotyping, ecological momentary assessment and interventions, wearable technology, computer-assisted tests, transcraneal magnetic stimulation, and virtual reality are just some examples of developments in a field that promises to create a real revolution in the assessment and treatment of addictions.

Humanities --- Social interaction --- addiction --- memory --- assessment --- substance use disorder --- internet gaming disorder --- semi-structured diagnostic interview --- psychometric properties --- adolescents --- drinking reduction --- nalmefene --- phase-IV trial --- 6 months --- observational --- gambling disorder (GD) --- cocaine use disorder (CUD) --- craving --- repetitive transcranial magnetic stimulation (rTMS) --- Gambling-Symptoms Assessment Scale (G-SAS) --- dorsolateral prefrontal cortex (DLPFC) --- alcohol dependence --- transdermal sensor --- attitudes --- stigma --- cerebellum --- cannabis --- implicit motor learning --- motor adaptation --- visuomotor rotation --- cannabidiol --- CBD --- psychosis --- schizophrenia --- substance use disorders --- alternative reward --- cue exposure --- animal and computational models --- behavioral control --- craving and relapse --- habit formation --- ALCO-VR --- virtual reality --- cue-exposure --- alcohol use disorder --- alcohol craving --- anxiety --- social drinkers --- Pavlovian-to-instrumental transfer --- amygdala --- alcohol --- polygenic risk --- high risk drinkers --- treatment --- assessment instruments --- digital health --- reward --- transgenic mice --- optogenetics --- self-administration --- cocaine --- amphetamine --- addiction --- memory --- assessment --- substance use disorder --- internet gaming disorder --- semi-structured diagnostic interview --- psychometric properties --- adolescents --- drinking reduction --- nalmefene --- phase-IV trial --- 6 months --- observational --- gambling disorder (GD) --- cocaine use disorder (CUD) --- craving --- repetitive transcranial magnetic stimulation (rTMS) --- Gambling-Symptoms Assessment Scale (G-SAS) --- dorsolateral prefrontal cortex (DLPFC) --- alcohol dependence --- transdermal sensor --- attitudes --- stigma --- cerebellum --- cannabis --- implicit motor learning --- motor adaptation --- visuomotor rotation --- cannabidiol --- CBD --- psychosis --- schizophrenia --- substance use disorders --- alternative reward --- cue exposure --- animal and computational models --- behavioral control --- craving and relapse --- habit formation --- ALCO-VR --- virtual reality --- cue-exposure --- alcohol use disorder --- alcohol craving --- anxiety --- social drinkers --- Pavlovian-to-instrumental transfer --- amygdala --- alcohol --- polygenic risk --- high risk drinkers --- treatment --- assessment instruments --- digital health --- reward --- transgenic mice --- optogenetics --- self-administration --- cocaine --- amphetamine

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Addiction in its various forms represents an enormous challenge to society. Worldwide, it has been estimated that alcohol, tobacco and illicit drugs were responsible of more than 10 million deaths (Anderson et al, 2018), with a higher impact in developed countries where substance use disorders have been identified as responsible for life expectancy reversals (Rehm et al, 2016). Societal and medical responses to the problem are far from optimal, but the appearance of new technologies offers room for improvement, and lots of new initiatives have been launched and developed. In this Special Issue, we will describe and discuss how these new tools are helping to improve the assessment and treatment of substance use disorders. We will cover a wide variety of novelties that are being applied to addiction; e-health, APPs, digital phenotyping, ecological momentary assessment and interventions, wearable technology, computer-assisted tests, transcraneal magnetic stimulation, and virtual reality are just some examples of developments in a field that promises to create a real revolution in the assessment and treatment of addictions.

addiction --- memory --- assessment --- substance use disorder --- internet gaming disorder --- semi-structured diagnostic interview --- psychometric properties --- adolescents --- drinking reduction --- nalmefene --- phase-IV trial --- 6 months --- observational --- gambling disorder (GD) --- cocaine use disorder (CUD) --- craving --- repetitive transcranial magnetic stimulation (rTMS) --- Gambling-Symptoms Assessment Scale (G-SAS) --- dorsolateral prefrontal cortex (DLPFC) --- alcohol dependence --- transdermal sensor --- attitudes --- stigma --- cerebellum --- cannabis --- implicit motor learning --- motor adaptation --- visuomotor rotation --- cannabidiol --- CBD --- psychosis --- schizophrenia --- substance use disorders --- alternative reward --- cue exposure --- animal and computational models --- behavioral control --- craving and relapse --- habit formation --- ALCO-VR --- virtual reality --- cue-exposure --- alcohol use disorder --- alcohol craving --- anxiety --- social drinkers --- Pavlovian-to-instrumental transfer --- amygdala --- alcohol --- polygenic risk --- high risk drinkers --- treatment --- assessment instruments --- digital health --- reward --- transgenic mice --- optogenetics --- self-administration --- cocaine --- amphetamine